BrightPath Biotherapeutics Co.,Ltd.

4594 TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥57.00
+0.00%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does BrightPath Biotherapeutics Co.,Ltd. belong to?
BrightPath Biotherapeutics Co.,Ltd. operates in the Pharmaceuticals sector, specifically the Pharmaceutical industry, and is listed on the US markets.
What is the current share price of 4594?
As of the latest available quote, 4594 traded at ¥57.00. This price is delayed and cached for about 15 minutes.
What is the market capitalisation of 4594?
The market capitalisation of BrightPath Biotherapeutics Co.,Ltd. is approximately ¥6.36B.
Is BrightPath Biotherapeutics Co.,Ltd. profitable?
For its latest reported financial year, BrightPath Biotherapeutics Co.,Ltd. recorded a negative net profit margin of about -999,999.99% (a net loss for the latest period).
Does 4594 pay a dividend?
BrightPath Biotherapeutics Co.,Ltd. does not currently show a dividend yield in our data.
What is the return on equity (ROE) of 4594?
BrightPath Biotherapeutics Co.,Ltd. has a return on equity (ROE) of about -55.57%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of 4594?
Over the past 52 weeks, 4594 has traded between a low of ¥43.00 and a high of ¥96.00.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.